ISRCTN01680675Completed未知
Pilot study to investigate the endocrinological, physiological and pain-reducing effects of gamma-hydroxybutyric acid in combination with operant behaviour pain therapy on patients with FibroMyalgia Syndrome
Charite - University Medicine Berlin (Charite - Universitatsmedizin Berlin) (Germany)0 sites40 target enrollmentStarted: February 6, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •1. Verified fibromyalgia
- •2. Female sex
- •3. Sound command of German language
- •4. Motivation for therapy
- •5. Minimum age 18 years
- •6. Written informed consent
Exclusion Criteria
- •1. Patients under 18 years or older than 80 years
- •2. Pregnancy
- •3. Psychiatric desease
- •4. Treatment with opioids
- •5. Treatment with sedative drugs
- •6. Current intake of anti-depressants
- •7. Pension demand
- •8. Patients without the possibility to give their consent
- •9. Arterial hypertension
- •10. Epilepsy
- •11. Severe renal failure
- •12. Intoxication with alcohol
- •13. Inclusion in another study within the last 30 days
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Pilotstudy about endocrinilogical, peripherphysilogical and painreducing effects of Gamma-hydroxybutyrate in combination with operant-behaviour-therapeutic paintherapy with patients in Fibromyalgia-Syndrome - GHB and OVT with patients in Fibromyalgia (FMS)EUCTR2005-002475-32-DECharitè Universitätmeditin Berlin
Completed
Phase 2
Can Volumetric modulated arc radiotherapy spare the thyroid gland in the treatment of head and neck cancersCTRI/2020/06/025863ONE26
Recruiting
Phase 2
Biomarkers to Detect Endocrine Therapy ResistanceMetastatic CancerLobular Breast CarcinomaBreast CancerNCT06067503University of Wisconsin, Madison8
Suspended
Phase 2
Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerBreast CancerNCT00738777The Netherlands Cancer Institute250
Completed
Not Applicable
Prospective Cohort Study of Endocrine Therapy with Abemaciclib for Chemotherapy-Treated Metastatic Breast CancerBreast cancerJPRN-UMIN000037395CSPOR-BC180